The activation of NF-κB is considered as one of the major reasons for cell adhesion-mediated drug resistance (CAM-DR). It has been reported that interferon regulatory factor-1 (IRF-1) plays an important role in NF-κB activation. Our research group have recently found that IRF-1 and EHD2 are involved in the process of CAM-DR of non-Hodgkin's lymphoma (NHL), and they can interact with each other. Furthermore, our preliminary study showed that EHD2 could promote the degradation of IRF-1. Based on these findings, we speculate that EHD2 may influence NF-κB activity by regulating IRF-1 expression,which may be critically involved in the process of CAM-DR. In this project, we aim to first establish NHL cell adhesion model, then analyse the interaction between EHD2 and IRF-1, as well as their regulatory mechanism. Moreover, the influence of the molecular mechanism on NF-κB activity and CAM-DR will be analyzed. Finally, we will clarify the correlation between the expression of EHD2 and IRF-1 in NHL clinical specimens, and investigate the role of EHD2-IRF-1 interaction in the process of CAM-DR utilizing nude mouse model. Our research may help to gain a better insight into the mechanism underlying CAM-DR and may be a promising therapeutic target.
NF-κB通路的活化是细胞粘附介导的耐药(CAM-DR)形成的重要原因之一。干扰素调节因子1(IRF-1)的表达在NF-κB活化中起重要作用。课题组前期研究发现IRF-1、EHD2与非霍奇金淋巴瘤(NHL)CAM-DR有关,并发现两者相互作用。预实验表明EHD2可调节IRF-1的降解。基于此,提出EHD2可能通过调节IRF-1的表达影响NF-κB通路参与CAM-DR进程。本课题拟首先构建NHL细胞粘附模型,分析EHD2与IRF-1在粘附过程中的相互作用及调节机制。其次,探讨其相互作用如何影响NF-κB通路进而影响CAM-DR进程。最后验证并分析EHD2、IRF-1与NHL患者的临床病理关系,并在耐药裸鼠模型中研究这种相互作用对NHL细胞CAM-DR的影响。课题的研究将进一步揭示NHL细胞CAM-DR发生发展的分子机制。
NF-κB 通路活化与细胞粘附介导的耐药(CAM-DR) 密切相关。根据前期工作基础我们提出假说:在淋巴瘤中EHD2与IRF-1相互作用可促进IRF-1泛素化降解,其相互作用通过激活NF-κB信号通路促进CAM-DR进程。为验证上述假说,我们首先在OCI-Ly8以及OCI-Ly10细胞中验证了EHD2与IRF-1的相互作用。接下来分析了EHD2对IRF-1蛋白表达水平的影响;通过放线菌酮追踪分析了EHD2对IRF-1半衰期的影响,同时分析了EHD2对IRF-1泛素化修饰的影响。通过CCK-8和台盼蓝拒染实验分析了EHD2、IRF-1对细胞增殖和死亡的影响。然后利用纤粘蛋白(FN)包被构建细胞粘附模型,免疫印记检测EHD2、IRF-1在悬浮及粘附培养过程中的表达变化。构建粘附模型,药物刺激实验分析EHD2、IRF-1对CAM-DR的影响。最后分析了EHD2与IRF-1相互作用对NF-κB通路活性的影响,并分析了其对NF-κB下游凋亡相关蛋白表达的影响。通过本项目的研究,已明确在淋巴瘤中EHD2与IRF-1相互作用可促进IRF-1泛素化降解,其相互作用通过激活NF-κB信号通路促进CAM-DR进程。课题的研究结果将进一步揭示CAM-DR发生发展的分子机制。
{{i.achievement_title}}
数据更新时间:2023-05-31
DNAgenie: accurate prediction of DNA-type-specific binding residues in protein sequences
奥希替尼治疗非小细胞肺癌患者的耐药机制研究进展
猪链球菌生物被膜形成的耐药机制
长链基因间非编码RNA 00681竞争性结合miR-16促进黑素瘤细胞侵袭和迁移
TRPV1/SIRT1介导吴茱萸次碱抗Ang Ⅱ诱导的血管平滑肌细胞衰老
β1整合素与TUBA1A的相互作用在非霍奇金淋巴瘤CAM-DR中的作用与意义
Numblike对β1 整合素的调节作用在非霍奇金淋巴瘤细胞粘附介导的耐药(CAM-DR)中的意义
病毒、化学致癌物和遗传因素相互作用与非霍奇金淋巴瘤关系的研究
胰岛因子1(ISL1)在非霍奇金淋巴瘤诊断中的作用及其分子机制研究